Evidence-Based Medicine Guidelines
Infliximab for maintenance of medically induced remission in Crohn's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Infliximab for Maintenance of Medically Induced Remission in Crohn's Disease." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454377/all/Infliximab_in_chronic_active_Crohn's_disease.
Infliximab for maintenance of medically induced remission in Crohn's disease. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/454377/all/Infliximab_in_chronic_active_Crohn's_disease. Accessed May 12, 2025.
Infliximab for maintenance of medically induced remission in Crohn's disease. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/454377/all/Infliximab_in_chronic_active_Crohn's_disease
Infliximab for Maintenance of Medically Induced Remission in Crohn's Disease [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454377/all/Infliximab_in_chronic_active_Crohn's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Infliximab for maintenance of medically induced remission in Crohn's disease
ID - 454377
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454377/all/Infliximab_in_chronic_active_Crohn's_disease
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
